{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:00:53Z","timestamp":1780117253199,"version":"3.54.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4031830"],"award-info":[{"award-number":["4031830"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["4031830"],"award-info":[{"award-number":["4031830"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-025-00579-6","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:11:53Z","timestamp":1764220313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effects of Calebin A and docetaxel on apoptosis and migration in prostate cancer cells"],"prefix":"10.1007","volume":"34","author":[{"given":"MohammadMostafa Askarnia","family":"Faal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tandiseh","family":"Tasbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Aliyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shojaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeen","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jalili-Nik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"579_CR1","doi-asserted-by":"publisher","first-page":"205520762513762","DOI":"10.1177\/20552076251376261","volume":"11","author":"M Chen","year":"2025","unstructured":"Chen M, Wu X, Chen L, Wang Y. The role of digital therapeutics in the management of prostate cancer: A systematic scoping review. Digit Health. 2025;11:20552076251376261.","journal-title":"Digit Health"},{"issue":"3","key":"579_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cpet.2024.03.011","volume":"19","author":"Y Yechiel","year":"2024","unstructured":"Yechiel Y, Chicheportiche A, Keidar Z, Ben-Haim S. Prostate cancer radioligand therapy: Beta-labeled radiopharmaceuticals. PET Clin. 2024;19(3):389\u201399.","journal-title":"PET Clin"},{"issue":"17","key":"579_CR3","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: Genetics, Diagnosis, treatment Options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules."},{"issue":"24","key":"579_CR4","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: A review. JAMA. 2017;317(24):2532\u201342.","journal-title":"JAMA"},{"key":"579_CR5","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song X-L, Li X-A, Chen M, Guo J, Yang D-H, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updates. 2023;68:100962.","journal-title":"Drug Resist Updates"},{"issue":"5","key":"579_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.37349\/etat.2024.00266","volume":"5","author":"N Thakur","year":"2024","unstructured":"Thakur N, Singh P, Bagri A, Srivastava S, Dwivedi V, Singh A, et al. Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies. Explor Target Anti-tumor Therapy. 2024;5(5):1110\u201334.","journal-title":"Explor Target Anti-tumor Therapy"},{"issue":"1","key":"579_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/PPO.0b013e3182801cf7","volume":"19","author":"RR Zielinski","year":"2013","unstructured":"Zielinski RR, Eigl BJ, Chi KN. Targeting the apoptosis pathway in prostate cancer. Cancer J. 2013;19(1):79\u201389.","journal-title":"Cancer J"},{"issue":"6","key":"579_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamaoncol.2024.0591","volume":"10","author":"M Hussain","year":"2024","unstructured":"Hussain M, Fizazi K, Shore ND, Heidegger I, Smith MR, Tombal B, et al. Metastatic Hormone-Sensitive prostate cancer and combination treatment outcomes: A review. JAMA Oncol. 2024;10(6):807\u201320.","journal-title":"JAMA Oncol"},{"issue":"5","key":"579_CR9","first-page":"1064","volume":"56","author":"X Wang","year":"2020","unstructured":"Wang X, Fang Y, Sun W, Xu Z, Zhang Y, Wei X, et al. Endocrinotherapy resistance of prostate and breast cancer: importance of the NF\u2013\u03baB pathway (Review). Int J Oncol. 2020;56(5):1064\u201374.","journal-title":"Int J Oncol"},{"issue":"11","key":"579_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garz\u00f3n","year":"2017","unstructured":"Murillo-Garz\u00f3n V, Kypta R. WNT signalling in prostate cancer. Nat Rev Urol. 2017;14(11):683\u201396.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"579_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000519861","volume":"100","author":"V Achard","year":"2022","unstructured":"Achard V, Putora PM, Omlin A, Zilli T, Fischer S. Metastatic prostate cancer: treatment options. Oncology. 2022;100(1):48\u201359.","journal-title":"Oncology"},{"issue":"12","key":"579_CR12","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3390\/nu11122904","volume":"11","author":"C Buhrmann","year":"2019","unstructured":"Buhrmann C, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Evidence that Calebin A, a component of curcuma longa suppresses NF-B mediated Proliferation, invasion and metastasis of human colorectal cancer induced by TNF-\u03b2 (Lymphotoxin). Nutrients. 2019;11(12):2904.","journal-title":"Nutrients."},{"issue":"1","key":"579_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejon.2008.10.003","volume":"13","author":"J Baker","year":"2009","unstructured":"Baker J, Ajani J, Scott\u00e9 F, Winther D, Martin M, Aapro MS, et al. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 2009;13(1):49\u201359.","journal-title":"Eur J Oncol Nurs"},{"issue":"6","key":"579_CR14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/cpt.3633","volume":"117","author":"HJ Lee","year":"2025","unstructured":"Lee HJ, Jeong YJ, Kim JS, Kim SJ, Jo U, Jun SJ, et al. Current status and future directions in the development of digital therapeutic interventions for neurodevelopmental disorders. Clin Pharmacol Ther. 2025;117(6):1632\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"579_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu JJ, Ding J. Natural products in cancer therapy: Past, present and future. Nat Prod Bioprospect. 2021;11(1):5\u201313.","journal-title":"Nat Prod Bioprospect"},{"key":"579_CR16","doi-asserted-by":"publisher","first-page":"106957","DOI":"10.1016\/j.bioorg.2023.106957","volume":"142","author":"Z Hui","year":"2024","unstructured":"Hui Z, Wen H, Zhu J, Deng H, Jiang X, Ye X-Y, et al. Discovery of plant-derived anti-tumor natural products: potential leads for anti-tumor drug discovery. Bioorg Chem. 2024;142:106957.","journal-title":"Bioorg Chem"},{"issue":"3","key":"579_CR17","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1039\/D4RA05089D","volume":"15","author":"K Kangra","year":"2025","unstructured":"Kangra K, Kakkar S, Mittal V, Kumar V, Aggarwal N, Chopra H, et al. Incredible use of plant-derived bioactives as anticancer agents. RSC Adv. 2025;15(3):1721\u201346.","journal-title":"RSC Adv"},{"key":"579_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells11081326","volume":"11","author":"AW Khan","year":"2022","unstructured":"Khan AW, Farooq M, Haseeb M, Choi S. Role of Plant-Derived active constituents in cancer treatment and their mechanisms of action. Cells. 2022;11:8.","journal-title":"Cells"},{"issue":"10","key":"579_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2174\/0109298673245074230925153031","volume":"32","author":"H Shamsnia","year":"2025","unstructured":"Shamsnia H, Samanian A, Kashani AS, Khayatan D, Momtaz S, Johnston TP, et al. An overview of the Pharmacological properties of Calebin-A. Curr Med Chem. 2025;32(10):2005\u201320.","journal-title":"Curr Med Chem"},{"issue":"10","key":"579_CR20","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1002\/jcp.26620","volume":"233","author":"L Hamzehzadeh","year":"2018","unstructured":"Hamzehzadeh L, Atkin SL, Majeed M, Butler AE, Sahebkar A. The versatile role of Curcumin in cancer prevention and treatment: A focus on PI3K\/AKT pathway. J Cell Physiol. 2018;233(10):6530\u20137.","journal-title":"J Cell Physiol"},{"key":"579_CR21","doi-asserted-by":"publisher","first-page":"104353","DOI":"10.1016\/j.phrs.2019.104353","volume":"147","author":"R Shafabakhsh","year":"2019","unstructured":"Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H. Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacol Res. 2019;147:104353.","journal-title":"Pharmacol Res."},{"issue":"10","key":"579_CR22","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2174\/0109298673245074230925153031","volume":"32","author":"H Shamsnia","year":"2025","unstructured":"Shamsnia H, Samanian A, Sabbagh Kashani A, Khayatan D, Momtaz S, Johnston TP, et al. An overview of the Pharmacological properties of Calebin-A. Curr Med Chem. 2025;32(10):2005\u201320.","journal-title":"Curr Med Chem."},{"issue":"1\u20133","key":"579_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ejphar.2008.06.065","volume":"591","author":"Y Li","year":"2008","unstructured":"Li Y, Li S, Han Y, Liu J, Zhang J, Li F, et al. Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells. Eur J Pharmacol. 2008;591(1\u20133):252\u20138.","journal-title":"Eur J Pharmacol"},{"key":"579_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.phymed.2017.08.021","volume":"34","author":"AK Tyagi","year":"2017","unstructured":"Tyagi AK, Prasad S, Majeed M, Aggarwal BB, Calebin A. A novel component of turmeric, suppresses NF-\u03baB regulated cell survival and inflammatory gene products leading to Inhibition of cell growth and chemosensitization. Phytomedicine. 2017;34:171\u201381.","journal-title":"Phytomedicine"},{"key":"579_CR25","doi-asserted-by":"crossref","unstructured":"Buhrmann C, Kunnumakkara AB, Popper B, Majeed M, Aggarwal BB, Shakibaei M. Calebin A Potentiates the Effect of 5-FU and TNF-\u03b2 (Lymphotoxin \u03b1) against Human Colorectal Cancer Cells: Potential Role of NF-\u03baB. Int J Mol Sci. 2020;21(7).","DOI":"10.3390\/ijms21072393"},{"key":"579_CR26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.abb.2016.02.013","volume":"593","author":"AK Tyagi","year":"2016","unstructured":"Tyagi AK, Prasad S, Majeed M, Aggarwal BB. Calebin A downregulates osteoclastogenesis through suppression of RANKL signalling. Arch Biochem Biophys. 2016;593:80\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"579_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.phymed.2019.01.001","volume":"57","author":"MJ Lee","year":"2019","unstructured":"Lee MJ, Tsai YJ, Lin MY, You HL, Kalyanam N, Ho CT, et al. Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase. Phytomedicine. 2019;57:377\u201384.","journal-title":"Phytomedicine"},{"key":"579_CR28","doi-asserted-by":"crossref","unstructured":"Ahmed IA, Hafiz S, van Ginkel S, Pondugula SR, Abdelhaffez AS, Sayyed HG et al. Augmentation of Docetaxel-Induced cytotoxicity in human PC-3 Androgen-Independent prostate cancer cells by combination with four natural Apoptosis-Inducing anticancer compounds. Nat Prod Commun. 2023;18(5):1934578X231175323.","DOI":"10.1177\/1934578X231175323"},{"key":"579_CR29","doi-asserted-by":"publisher","first-page":"121504","DOI":"10.1016\/j.lfs.2023.121504","volume":"318","author":"A Brockmueller","year":"2023","unstructured":"Brockmueller A, Samuel SM, Mazurakova A, B\u00fcsselberg D, Kubatka P, Shakibaei M. Curcumin, Calebin A and chemosensitization: how are they linked to colorectal cancer? Life Sci. 2023;318:121504.","journal-title":"Life Sci"},{"issue":"10","key":"579_CR30","doi-asserted-by":"publisher","first-page":"9623","DOI":"10.1007\/s11033-022-07867-3","volume":"49","author":"F Qoorchi Moheb Seraj","year":"2022","unstructured":"Qoorchi Moheb Seraj F, Heravi-Faz N, Soltani A, Ahmadi SS, Shahbeiki F, Talebpour A, et al. Thymol has anticancer effects in U-87 human malignant glioblastoma cells. Mol Biol Rep. 2022;49(10):9623\u201332.","journal-title":"Mol Biol Rep"},{"key":"579_CR31","first-page":"163","volume":"57","author":"M Toth","year":"2001","unstructured":"Toth M, Fridman R. Assessment of gelatinases (MMP-2 and MMP-9 by gelatin zymography. Methods Mol Med. 2001;57:163\u201374.","journal-title":"Methods Mol Med"},{"key":"579_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/7651_2019_259","volume":"2109","author":"S Martinotti","year":"2020","unstructured":"Martinotti S, Ranzato E. Scratch wound healing assay. Methods Mol Biol. 2020;2109:225\u20139.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"579_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63\u201389.","journal-title":"World J Oncol"},{"key":"579_CR34","doi-asserted-by":"crossref","unstructured":"Pan M-h, Chiou Y-s, Kalyanam N, Ho C-T, Ding B, editors. Preparation of Calebin-A Liposomes and its Antiproliferation in Human Cancer Cells2017.","DOI":"10.15406\/japlr.2017.05.00137"},{"key":"579_CR35","doi-asserted-by":"publisher","first-page":"962066","DOI":"10.3389\/fonc.2022.962066","volume":"12","author":"A Brockmueller","year":"2022","unstructured":"Brockmueller A, Mueller AL, Kunnumakkara AB, Aggarwal BB, Shakibaei M. Multifunctionality of Calebin A in inflammation, chronic diseases and cancer. Front Oncol. 2022;12:962066.","journal-title":"Front Oncol"},{"key":"579_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jff.2016.08.047","volume":"26","author":"W-S Liou","year":"2016","unstructured":"Liou W-S, Lin C, Lee P-S, Kalyanam N, Ho C-T, Pan M-H. Calebin-A induces cell cycle arrest in human colon cancer cells and xenografts in nude mice. J Funct Foods. 2016;26:781\u201391.","journal-title":"J Funct Foods"},{"issue":"7","key":"579_CR37","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/ijms21072393","volume":"21","author":"C Buhrmann","year":"2020","unstructured":"Buhrmann C, Kunnumakkara AB, Popper B, Majeed M, Aggarwal BB, Shakibaei M. Calebin A potentiates the effect of 5-FU and TNF-\u03b2 (Lymphotoxin \u03b1) against human colorectal cancer cells: potential role of NF-\u03baB. Int J Mol Sci. 2020;21(7):2393.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"579_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/biomedicines8080236","volume":"8","author":"C Buhrmann","year":"2020","unstructured":"Buhrmann C, Shayan P, Banik K, Kunnumakkara AB, Kubatka P, Koklesova L, et al. Targeting NF-\u03baB signaling by Calebin A, a compound of Turmeric, in multicellular tumor microenvironment: potential role of apoptosis induction in CRC cells. Biomedicines. 2020;8(8):236.","journal-title":"Biomedicines."}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-025-00579-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:05:44Z","timestamp":1780113944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-025-00579-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1007\/s40199-025-00579-6","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All experiments were conducted following institutional ethics (code of ethics:\u00a0IR.MUMS.MEDICAL.REC.1403.464).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors did not report any conflicts of interest in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}